Recombinant factor VIIa use in patients presenting with intracranial hemorrhage

Recombinant factor VIIa (rFVIIa) can be used for rapid INR normalization in life-threatening hemorrhage in anticoagulated patients. Dosing is unclear and may carry thromboembolic risks. We reviewed the use of rFVIIa at a comprehensive stroke and cerebrovascular center to evaluate dose effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Yampolsky, Natalie, Stofko, Douglas, Veznedaroglu, Erol, Liebman, Kenneth, Binning, Mandy J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155054/
https://www.ncbi.nlm.nih.gov/pubmed/25197623
http://dx.doi.org/10.1186/2193-1801-3-471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155054/
https://www.ncbi.nlm.nih.gov/pubmed/25197623
http://dx.doi.org/10.1186/2193-1801-3-471

Ejemplares similares